![[In-depth] Halved Immediately After Reaching Kosdaq #1... Jeon In-seok, CEO of Samyang T&D Pharmaceutical, Ultimately Withdraws 250 Billion Won Block Deal](https://lh3.googleusercontent.com/J6_coFbogxhRI9iM864NL_liGXvsQp2AupsKei7z0cNNfDvGUmWUy20nuUhkREQyrpY4bEeIBuc=s0-w300-rw)
[In-depth] Halved Immediately After Reaching Kosdaq #1... Jeon In-seok, CEO of Samyang T&D Pharmaceutical, Ultimately Withdraws 250 Billion Won Block Deal
Jeon In-seok, CEO of Samyang T&D Pharmaceutical, ultimately withdrew a 250 billion won block deal after the company's stock price halved immediately after briefly becoming the top Kosdaq company.
Key takeaway
"[In-depth] Halved Immediately After Reaching Kosdaq #1... Jeon In-seok, CEO of Samyang T&D Pharmaceutical, Ultimately Withdraws 250 Billion Won Block Deal" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 10 out of 100. Jeon In-seok, CEO of Samyang T&D Pharmaceutical, ultimately withdrew a 250 billion won block deal after the company's stock price halved immediately after briefly becoming the top Kosdaq company. Reported by Google News Stock Market on April 06, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 53.2%.